JOURNAL REPORT 2020
2018 | 2019 | 2020

Multiple Sclerosis International

Total articles submitted to this journal each month during 2020.
Total articles published in this journal each month during 2020.
6

Total authors

Total unique authors of published articles in this journal during 2020.
1

Total published articles

Total articles published in this journal during 2020.
N/A

Days

Average time from submission to acceptance

103

Days

Average time from acceptance to publication

9

Total submitted articles

Total articles submitted to this journal during 2020.
0

Total accepted articles

Total articles accepted for publication in this journal during 2020.

Most Viewed Articles

ArticleViews
“Calcitriol” is Not Synonymous with “Vitamin D”518
Intrathecal IgG synthesis: a resistant and valuable target for future multiple sclerosis treatments.360
Enduring Clinical Value of Copaxone® (Glatiramer Acetate) in Multiple Sclerosis After 20 Years of Use284
Occupational therapy in the fatigue management in multiple sclerosis: an umbrella review275
Adding to the burden: Gastrointestinal symptoms and syndromes in multiple sclerosis273
The efficacy of functional electrical stimulation of the abdominal muscles in the treatment of chronic constipation in patients with multiple sclerosis - a pilot study257
Spatial Analysis of Global Prevalence of Multiple Sclerosis Suggests Need for an Updated Prevalence Scale238
The therapeutic potential of the Ketogenic Diet in treating progressive multiple sclerosis229
The prevalence of anti Aquaporin 4 antibody in patients with Idiopathic Inflammatory Demyelinating Diseases presented to a Tertiary Hospital in Malaysia: Presentation and prognosis.218
Brain abnormalities in neuromyelitis optica spectrum disorder198

Most Viewed Special Issue Articles

ArticleViews
SERUM METABOLIC PROFILE IN MULTIPLE SCLEROSIS PATIENTS150
DTI measurements in Multiple Sclerosis: evaluation of brain damage and clinical implications148
Outcome measures in relapsing-remitting multiple sclerosis: capturing disability and disease progression in clinical trials145
Evaluating the Role of Optical Coherence Tomography in Optic Neuritis122
Iron and neurodegeneration in multiple sclerosis85
Factors for Lower Walking Speed in Persons with Multiple Sclerosis74
Measuring the quality of life in patients with multiple sclerosis in clinical practice: a necessary challenge70
Hyperacute Corticosteroid Treatment of Optic Neuritis at the Onset of Pain may prevent Visual Loss: A Case Series68
Assessment of definitions of sustained disease progression in relapsing-remitting multiple sclerosis62
Neurofilament proteins as body fluid biomarkers of neurodegeneration in multiple sclerosis58

Key Indexes